ANKMJ
Ankyra Medical Journal

Ankyra Medical Journal (AnkMJ), formerly known as the Journal of Translational and Practical Medicine, regularly publishes international quality issues in the field of Medicine in the light of current information.

eISSN: 3023-655X
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Letter to the Editor
Comparison of novel oxidative stress and systemic inflammation marker levels in patients with bipolar disorder and schizophrenia
Abstract
Bipolar disorder (BD) and schizophrenia (SCZ) are chronic mental disorders with mood and psychotic episodes, respectively, which significantly affect functioning and quality of life.

Keywords : Neutrophil/high-density lipoprotein ratio, lymphocyte/HDL ratio, monocyte/HDL ratio, platelet/HDL ratio, atherogenic index of plasma, atherogenic coefficient

Download Article


1. Misiak B, Bartoli F, Carra G, et al. Chemokine alterations in bipolardisorder: a systematic review and meta-analysis. Brain, Behav, Immun.2020;88:870-877.
2. Wei Y, Wang T, Li G, et al. Investigation of systemic immune-inflammation index, neutrophil/high-density lipoprotein ratio,lymphocyte/high-density lipoprotein ratio, and monocyte/high-density lipoprotein ratio as indicators of inflammation in patients withschizophrenia and bipolar disorder. Front Psychiatry. 2022;13:941728.
3. McIntyre RS. A vision for drug discovery and development: noveltargets and multilateral partnerships. Adv Ther. 2014;31(3):245-246.
4. Korkmaz ŞA, Kızgın S. Neutrophil/high-density lipoprotein cholesterol(HDL), monocyte/HDL and platelet/HDL ratios are increased inacute mania as markers of inflammation, even after controlling forconfounding factors. Curr Med Res Opin. 2023;39(10):1383-1390.
5. Wei Y, Gao H, Luo Y, et al. Systemic inflammation and oxidative stressmarkers in patients with unipolar and bipolar depression: a large-scalestudy. J Affect Dis. 2024;346:154-166.
6. Kılıç N, Tasci G, Yılmaz S, et al. Monocyte/HDL cholesterol ratios asa new inflammatory marker in patients with schizophrenia. J PersonalMed. 2023;13(2):276.
Article available in :
Volume 3, Issue 2, 2024
Page : 54-55
https://doi.org/10.51271/ANKMJ-0011
Article Information
Received : 05 Şub 2024
Accepted : 28 Şub 2024
Published : 26 Mar 2024
Corresponding Author :

Şükrü Alperen Korkmaz: Çanakkale Onsekiz Mart University, Faculty of Medicine, Department of Psychiatry

[email protected]
Citation : Korkmaz ŞA. Comparison of novel oxidative stress and systemic inflammation marker levels in patients with bipolar disorder and schizophrenia. Ank Med J. 2024;3(2):54-55.

Read: 164
Cited: 0
Download : 147
_Footer